
WaveAcid builds a handheld device that enables on-demand synthesis of pharmaceutical and biochemical precursors. The system combines computational synthesis driven by neural networks with a sealed multistep synthesis cartridge to produce and purify intermediates. The hardware uses analytical sensors—infrared spectrometry, nuclear magnetic resonance—and vacuum retrieval caches, controlled by a RISC‑V CPU and a GTX‑class GPU for on‑device computation. WaveAcid is a hardware company in the biotech and chemical synthesis category supplying laboratory and clinical‑scale synthesis tools. The company targets regulated drug and precursor manufacturing workflows and development labs exploring decentralized or point‑of‑care production.

WaveAcid builds a handheld device that enables on-demand synthesis of pharmaceutical and biochemical precursors. The system combines computational synthesis driven by neural networks with a sealed multistep synthesis cartridge to produce and purify intermediates. The hardware uses analytical sensors—infrared spectrometry, nuclear magnetic resonance—and vacuum retrieval caches, controlled by a RISC‑V CPU and a GTX‑class GPU for on‑device computation. WaveAcid is a hardware company in the biotech and chemical synthesis category supplying laboratory and clinical‑scale synthesis tools. The company targets regulated drug and precursor manufacturing workflows and development labs exploring decentralized or point‑of‑care production.
Product: Handheld device for autonomous on-demand synthesis of pharmaceutical compounds
Tech: AI-driven computational chemistry, neural-network controllers, onboard analytical sensors (IR, NMR), vacuum systems, RISC-V edge compute with GPU-class acceleration
Target customers: Research labs and clinical or point-of-care settings
Founded: 2017
Automating and decentralizing small-molecule and biochemical synthesis to accelerate research and enable point-of-care/localized medicine production.
2017
Biotechnology
1008039